Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
belagenpumatucel-l (3 trials)
Carcinoma (Phase 3)
Carcinoma, Bronchogenic (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Lung Neoplasms (Phase 3)
Trials (3 total)
Trial APIs (1 total)